Company / Capital Expenditures
Progyny Capital Expenditures History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$18.4M
FY2025
5-year range
$2.1M / $18.4M
FY2021-FY2025
Trend
+240.6%
vs FY2024
Sector context
#102 of 145
Health Care
What the data says
Capital Expenditures changed +241% YoY in FY2025, a notable deviation from the 8-year average annual change of +100%.
Based on SEC 10-K filings.
$18M in FY2025 with a 5-year CAGR of +77.8%.
Improved from $4M to $18M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +78.4%
- 5-Year CAGR
- +77.8%
- 10-Year CAGR
- -
Sector benchmark
#102 of 145 in Health CareTop 70% of 145This company $18.4M Sector average $268.6M
▼
-93.1% below sector average
Key checks
Key Insights
- Progyny's capital expenditures has grown for 5 consecutive years.
- 5-year CAGR of +77.8%, indicating consistent growth.
- In FY2025, capital expenditures increased 240.6% year-over-year.
- Ranks #102 out of 145 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.62 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.4M | +240.6% |
| FY2024 | $5.4M | +48.3% |
| FY2023 | $3.6M | +12.4% |
| FY2022 | $3.2M | +52.2% |
| FY2021 | $2.1M | +105.3% |
| FY2020 | $1.0M | -64.9% |
| FY2019 | $3.0M | +410.5% |
| FY2018 | $579.0K | -5.4% |
| FY2017 | $612.0K | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026